US Broker Ratings

ICON plc (ICLR) Investor Outlook: Analyzing a Strong 17% Upside Potential

For investors with a keen eye on the healthcare sector, ICON plc (NASDAQ: ICLR) offers a compelling opportunity. Based in Dublin, Ireland, ICON plc is a..

BeOne Medicines Ltd. (ONC) Investor Outlook: Strong Buy Ratings and a Promising 23.13% Upside Potential

BeOne Medicines Ltd. (ONC), a major player in the biotechnology sector, is rapidly making its mark with a robust pipeline of oncology treatments. Based in Switzerland,..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring a 13% Upside Potential in the Biotech Sector

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotech sector, not only due to its innovative cancer treatments but also because of its current market performance..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating Healthcare’s Investment Landscape with a 6.83% Upside

As the healthcare sector continues to be a focal point for investors seeking stability and growth, Universal Health Services, Inc. (NYSE: UHS) stands out with its..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Healthcare Sector Dynamics with Strategic Insights

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, continues to be a focal point for investors looking to capitalize on the evolving landscape..

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Leader with 14% Potential Upside

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector specializing in diagnostics and research, offers an intriguing opportunity for investors seeking exposure to a..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A Look at Its 7.45% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of..

Danaher Corporation (DHR) Stock Analysis: Strong Buy Ratings Signal Promising 14% Upside

Danaher Corporation (NYSE: DHR) stands as a formidable entity in the healthcare sector, primarily operating within the diagnostics and research industry. With a commanding market capitalization..

IDEXX Laboratories (IDXX) Stock Analysis: Strong Revenue Growth and Strategic Market Position

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Novartis AG (NVS): Investor Outlook on a Healthcare Giant with a 3.06% Dividend Yield

Novartis AG (NYSE: NVS), a behemoth in the global healthcare sector, continues to capture investor attention with its robust market position and substantial dividend yield. As..

Genmab A/S (GMAB) Stock Analysis: Strong Growth and 25.84% Upside Potential Captivate Investors

Genmab A/S (GMAB), a prominent player in the biotechnology sector, stands out on the global stage with a market capitalization of $18.4 billion. Based in Denmark,..

argenx SE (ARGX) Stock Analysis: Strong Buy Ratings Propel Growth Prospects

argenx SE (ARGX), a dynamic player in the biotechnology sector, has captured the attention of the investment community with its impressive growth trajectory and robust analyst..

McKesson Corporation (MCK) Stock Analysis: Navigating Growth and Opportunities in the Healthcare Sector

Investors keeping an eye on the healthcare sector might find McKesson Corporation (NYSE: MCK) an intriguing prospect. With a market capitalization of $99.72 billion, McKesson stands..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare Growth with a 5.66% Upside

Centene Corporation (NYSE: CNC) stands out in the healthcare sector as a major player in the healthcare plans industry. With a market capitalization of $16.73 billion,..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 50.71% Potential Upside Amidst Biotech Challenges

Moderna, Inc. (NASDAQ: MRNA) has become a household name, primarily due to its groundbreaking work in mRNA vaccines, most notably its COVID-19 vaccine. However, the company’s..

Abbott Laboratories (ABT) Stock Analysis: Navigating a 13.89% Potential Upside in the Healthcare Sector

Abbott Laboratories (NYSE: ABT), a prominent player in the healthcare sector, offers a compelling opportunity for investors seeking exposure to the medical devices industry. With a..

Royalty Pharma plc (RPRX) Investor Outlook: Unlocking a 19.43% Upside with Strategic Biopharma Royalties

Royalty Pharma plc (NASDAQ: RPRX), a prominent player in the biotechnology industry, is strategically positioned at the intersection of healthcare and investment, offering investors a unique..

Insmed Incorporated (INSM) Stock Analysis: A Biotech Leader with 8.10% Upside Potential

For investors eyeing the biotechnology sector, Insmed Incorporated (NASDAQ: INSM) presents a compelling opportunity. Headquartered in Bridgewater, New Jersey, Insmed specializes in developing and commercializing therapies..

West Pharmaceutical Services (WST) Stock Analysis: A Healthcare Giant with a 17.54% Upside Potential

Investors looking for opportunities in the healthcare sector may find West Pharmaceutical Services, Inc. (NYSE: WST) an intriguing proposition. With a market capitalization of $21.4 billion,..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Evaluating a 11.78% Potential Upside

GE HealthCare Technologies Inc. (GEHC), a prominent player in the health information services industry, has captured the attention of investors with a notable potential upside of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds